In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D002845:Chromatography; D003165:Complement System Proteins; D007106:Immune Sera / Q000494:pharmacology; D007108:Immune Tolerance; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G / Q000494:pharmacology; D008198:Lymph Nodes / Q000166:cytology; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D011817:Rabbits / Q000276:immunology; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology; D013950:Thymus Gland / Q000166:cytology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007106:Immune Sera; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D003165:Complement System Proteins